European Generic Markets: Regulatory Approaches Across the EU in 2025
Europe's generic drug market operates under a complex four-path regulatory system. As of 2025, major reforms are accelerating approvals, cutting protection periods, and forcing supply transparency-changing how generics enter the market.
read more